Skip to main content

Otero Jose Manuel's Form 4 filing

Lexeo Therapeutics, Inc.LXEO · filed Nov 20, 2025

Accession no.
0002024096-25-000005
Filed
Nov 20, 2025
Trade date
Aug 18, 2025
Filing delay
94 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $6.68K. It was filed 94 days after the trade, past the 2-business-day deadline.

This filing was later replaced by the amendment 0002024096-26-000004 (Feb 20, 2026). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Otero Jose ManuelCIK 0002024096Officer (Chief Technical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 18, 2025Common StockSSaleDisposed−721$9.27F2−$6,683.6763,476Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $9.09 to $9.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)